Phase II trial of ambroxol as a disease modifying therapy for Parkinson’s disease dementia
Phase II trial of ambroxol as a disease m... - Cure Parkinson's
Phase II trial of ambroxol as a disease modifying therapy for Parkinson’s disease dementia
Read more about...
3 Replies
•
Good stuff. The more non-motor-symptom therapies being trialled the better, IMO.
very clear and detailed explanation of the trial and state of play. Excellent! Fingers crossed!
Not what you're looking for?
You may also like...
Potential disease-modifying therapy enters Phase 2
review of the data of the 101 trial, the drug advanced to the Phase II 201 trial (NCT05424276)....
Light Therapy for Parkinson’s Disease
light therapy information together in one place:...
AD/PD 2024: early diagnosis key for disease-modifying therapies in Parkinson’s
disease-modifying-therapies-in-parkinsons/?cf-view
Electroconvulsive Therapy Intervention for Parkinson’s Disease
before: Electroconvulsive Therapy Intervention for Parkinson’s Disease...
Parkinson’s disease stem cell therapy research update
stem cells for Parkinson’s....